 |
 |
|
|
RESÚMENES OCTUBRE 2004 |
Child Disorders
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Understanding the
neurobiological consequences of early exposure to psychotropic drugs: linking
behavior with molecules
William A.
Carlezon, Jr. and Christine Konradi
Neuropharmacology.
Volume 47, Supplement 1, 2004, Pages 47-60
The prevalence
of dyslexia and AD/HD in a sample of forensic psychiatric rapists
Anna M. Dåderman, May
Lindgren, Lars Lidberg
Nordic Journal of Psychiatry. Volume 58, Number 5 /
October 2004: 371 - 381
Child and
adolescent clinical features as forerunners of adult-onset major depressive
disorder: retrospective evidence from an epidemiological sample
Holly C. Wilcox and
James C. Anthony
Antonio Y. Hardan,
Roger J. Jou, Matcheri S. Keshavan, Ravi Varma and Nancy J. Minshew
Assessing
methylphenidate preference in ADHD patients using a choice procedure
Emily MacDonald Fredericks
and Scott H. Kollins
Psychopharmacology 2004; Volume 175, Number
4: 391 - 398
Child maltreatment
and HPA axis dysregulation: relationship to major depressive disorder and post
traumatic stress disorder in females
Alison Shea,
Christine Walsh, Harriet MacMillan and Meir Steiner
Efficacy
of two once-daily methylphenidate formulations compared across dose levels at
different times of the day: Preliminary indications from a secondary analysis
of the COMACS study data
Edmund
J. S. Sonuga-Barke, James M. Swanson, David Coghill, Heleen H. DeCory and Simon
J. Hatch
BMC Psychiatry 2004, 4:28
Zinc
sulfate as an adjunct to methylphenidate for the treatment of attention deficit
hyperactivity disorder in children: A double blind and randomized trial
[ISRCTN64132371]
Shahin
Akhondzadeh, Mohammad-Reza Mohammadi and Mojgan Khademi
BMC Psychiatry 2004, 4:9
Risk
factors for eating disorders in adolescents. A Spanish community-based
longitudinal study
Luis Beato-Fernández,
Teresa Rodríguez-Cano, Antonia Belmonte-Llario and
Cristóbal Martínez-Delgado
European Child & Adolescent Psychiatry 2004;
Volume 13, Number 5: 287 - 294
Good outcome of
adolescent onset anorexia nervosa after systematic treatment. Intermediate to
long-term follow-up of a representative county-sample
Inger Halvorsen,
Anne Andersen and Sonja Heyerdahl
European Child & Adolescent Psychiatry 2004;
Volume 13, Number 5: 295 - 306
The clinical
necessity for assessing Attention Deficit/Hyperactivity Disorder (AD/HD)
symptoms in children with high-functioning Pervasive Developmental Disorder
(PDD)
Yuko Yoshida
and Tokio Uchiyama
European Child & Adolescent Psychiatry
2004; Volume 13, Number 5: 307 - 314
Attention-deficit/hyperactivity
disorder (ADHD): parents’ judgment about school, teachers’ judgment about home
Pieter F. A de Nijs,
Robert F. Ferdinand, Esther I. de Bruin,
Marieke C. J. Dekker, Cornelia M. van Duijn and
Duijn C. Verhulst
European Child & Adolescent Psychiatry 2004;
Volume 13, Number 5: 315 - 320
Effect
of carbamazepine and valproate on bone mineral density
Ecevit C, Aydogan A,
Kavakli TU, Altinoz S.
Pediatr Neurol. 2004 Oct;31(4):279-282
Effects of acute
nicotine administration on behavioral inhibition in adolescents with
attention-deficit/hyperactivity disorder
Alexandra S. Potter
and Paul A. Newhouse
Psychopharmacology 2004; Volume 176, Number
2: 183 - 194
Improvement in health-related quality of life in children with ADHD: An
analysis of placebo controlled studies of atomoxetine.
Perwien AR, Faries DE, Kratochvil CJ, Sumner CR,
Kelsey DK, Allen AJ.
Once-daily atomoxetine treatment for children with
attention-deficit/hyperactivity disorder, including an assessment of evening
and morning behavior: a double-blind, placebo-controlled trial.
Kelsey DK, Sumner CR, Casat CD, et al.
The incidence and
prevalence of pervasive developmental disorders: a Danish population-based
study
M.
B. LAURITSEN, C. B. PEDERSEN and P. B. MORTENSEN
Psychological Medicine (2004), 34:7:1339-1346
Review:
relying on published data alone overestimates efficacy and safety of SSRIs in
children
Mark L Wolraich